These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35667304)

  • 21. [Role of antiviral drugs in containing pandemic influenza. Contribution of recent modelling exercises synthesis prepared by the InVS/Inserm "epidemiology" group - November 2005].
    Lévy-Bruhl D
    Med Mal Infect; 2006 Sep; 36(9):449-53. PubMed ID: 17027218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mathematical modeling of the novel influenza A (H1N1) virus and evaluation of the epidemic response strategies in the Republic of Korea].
    Suh M; Lee J; Chi HJ; Kim YK; Kang DY; Hur NW; Ha KH; Lee DH; Kim CS
    J Prev Med Public Health; 2010 Mar; 43(2):109-16. PubMed ID: 20383043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the effectiveness of interventions used during the 2009 A/H1N1 influenza pandemic.
    Halder N; Kelso JK; Milne GJ
    BMC Public Health; 2010 Mar; 10():168. PubMed ID: 20346187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of Antiviral Allocation Scheme for Pandemic Influenza Depends on Strain Transmissibility, Delivery Delay and Stockpile Size.
    Lydeamore M; Bean N; Black AJ; Ross JV
    Bull Math Biol; 2016 Feb; 78(2):293-321. PubMed ID: 26846916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics.
    Carrat F; Luong J; Lao H; Sallé AV; Lajaunie C; Wackernagel H
    BMC Med; 2006 Oct; 4():26. PubMed ID: 17059593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can antiviral drugs contain pandemic influenza transmission?
    Becker NG; Wang D
    PLoS One; 2011 Mar; 6(3):e17764. PubMed ID: 21464934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness.
    Venkatesan S; Carias C; Biggerstaff M; Campbell AP; Nguyen-Van-Tam JS; Kahn E; Myles PR; Meltzer MI
    J Public Health (Oxf); 2019 Jun; 41(2):379-390. PubMed ID: 29955851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines and antiviral drugs in pandemic preparedness.
    Monto AS
    Emerg Infect Dis; 2006 Jan; 12(1):55-60. PubMed ID: 16494718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpile.
    McCaw JM; Wood JG; McBryde ES; Nolan TM; Wu JT; Lipsitch M; McVernon J
    Med J Aust; 2009 Aug; 191(3):136-7. PubMed ID: 19645639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pandemic influenza: overview of vaccines and antiviral drugs.
    Cox MM
    Yale J Biol Med; 2005 Oct; 78(5):321-8. PubMed ID: 17132338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare system cost evaluation of antiviral stockpiling for pandemic influenza preparedness.
    Li Y; Hsu EB; Links JM
    Biosecur Bioterror; 2010 Jun; 8(2):119-28. PubMed ID: 20569054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential impact of antiviral drug use during influenza pandemic.
    Gani R; Hughes H; Fleming D; Griffin T; Medlock J; Leach S
    Emerg Infect Dis; 2005 Sep; 11(9):1355-62. PubMed ID: 16229762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Containing pandemic influenza at the source.
    Longini IM; Nizam A; Xu S; Ungchusak K; Hanshaoworakul W; Cummings DA; Halloran ME
    Science; 2005 Aug; 309(5737):1083-7. PubMed ID: 16079251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
    Lugnér AK; Postma MJ
    Eur J Public Health; 2009 Oct; 19(5):516-20. PubMed ID: 19692550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis.
    Kelso JK; Halder N; Milne GJ
    BMC Infect Dis; 2013 Feb; 13():81. PubMed ID: 23398722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic.
    McCaw JM; McVernon J
    Math Biosci; 2007 Oct; 209(2):336-60. PubMed ID: 17416393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analysis of pandemic influenza vaccination strategies in Singapore.
    Lee VJ; Tok MY; Chow VT; Phua KH; Ooi EE; Tambyah PA; Chen MI
    PLoS One; 2009 Sep; 4(9):e7108. PubMed ID: 19771173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.
    Siddiqui MR; Edmunds WJ
    Emerg Infect Dis; 2008 Feb; 14(2):267-74. PubMed ID: 18258120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stockpiling antiviral drugs for the next influenza pandemic.
    Patel A; Gorman SE
    Clin Pharmacol Ther; 2009 Sep; 86(3):241-3. PubMed ID: 19707215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiviral resistance and the control of pandemic influenza.
    Lipsitch M; Cohen T; Murray M; Levin BR
    PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.